TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
28/08/2025
Voltar para busca
Dado oficial do USPTO
ZEALAND PHARMA A/S
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
ZEALAND PHARMA A/S
ST13
US500000086842067Classe
1, 5, 42, 44
Pedido
86842067
Registro
5597662
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
61
Atualização mais recente
30/08/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 42, 44
Data de depósito
08/12/2015
Data de registro
30/10/2018
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
28/07/2025
Última transação
30/08/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
704
Cadastro oficial
Supplemental Register
Fundamento do pedido
Intent to use
Código do desenho
4
Tipo de titular
99
Localização do titular
Søborg, DK
Examinador
KEELEY, ALISON
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Zealand Pharma A/S
Zealand Pharma A/S
Representantes
Miriam D. Trudell Davis Graham & Stubbs LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
(Based on Section 44(e)) Biomedical compoundspeptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use; peptide substrates used in analyzing and detecting certain toxins for laboratory or research use
Classe 5
(Based on Section 44(e)) Pharmaceutical preparations for the treatment of diseasesillnesses and ailments in humans and animalsendocrine disordersnutritional and metabolic diseasesimmunity disordersblood disordersdisorders of the nervous system and sensory organsmusculoskeletal system disordersconnective tissue disorderscirculatory system disordersrespiratory system disordersdigestive system and genitourinary system disordersskin disorders; chemical preparations for medical and pharmaceutical purposesfor the treatment of diseasesillnesses and ailments in humans and animalsendocrine disordersnutritional and metabolic diseasesimmunity disordersblood disordersdisorders of the nervous system and sensory organsmusculoskeletal system disordersconnective tissue disorderscirculatory system disordersrespiratory system disordersdigestive system and genitourinary system disordersskin disorders; first aid kits; diagnostic kits comprised of pharmaceutical and chemical preparations for the treatment of diseasesillnessesailments in humans and animalsendocrine disordersnutritional and metabolic diseasesimmunity disordersblood disordersdisorders of the nervous system and sensory organsmusculoskeletal system disordersconnective tissue disorderscirculatory system disordersrespiratory system disordersdigestive system and genitourinary system disordersskin disorders
Classe 42
(Based on Section 44(e)) Scientific and technological services and research and design relating thereto in the field of medicinepharmaceuticalsgeneticsbiology and biotechnologyresearchdesign of peptides and pharmaceutical drugsmedical and scientific laboratory servicesscientific and medical research consulting servicesmedical researchanalysis and testing in the field of diseasesillnesses and ailments in humans and animals for scientific and research purposesin the fields of endocrine disordersnutritional and metabolic diseasesimmunity disordersblood disordersdisorders of the nervous system and sensory organsmusculoskeletal system disordersconnective tissue disorderscirculatory system disordersrespiratory system disordersdigestive system and genitourinary system disordersskin disorders; industrial analysis and research services in the field of medicinepharmaceuticalsgeneticsbiology and biotechnology; design and development of computer hardware and software; medicalbiologicalbiotechnologicalgeneticlaboratory and pharmaceutical researchdesign and development servicesthe development of medicines for the treatment of diseasesillnesses and ailments in humans and animalsendocrine disordersnutritional and metabolic diseasesimmunity disordersblood disordersdisorders of the nervous system and sensory organsmusculoskeletal system disordersconnective tissue disorderscirculatory system disordersrespiratory system disordersdigestive system and genitourinary system disordersskin disorders; laboratory research in the field of medicinepharmaceuticalsgeneticsbiology and biotechnology; information and consultancy services relating to all the aforesaidinformation and consultancy services relating to the development of medicines for the treatment of diseasesillnesses and ailments in humans and animalsendocrine disordersnutritional and metabolic diseasesimmunity disordersblood disordersdisorders of the nervous system and sensory organsmusculoskeletal system disordersconnective tissue disorderscirculatory system disordersrespiratory system disordersdigestive system and genitourinary system disordersskin disorders
Classe 44
(Based on Section 44(e)) Medical services; veterinary services; hygienic and beauty care for human beings or animals; horticulture services; dentistry services; medical analysis of peptide based medicines for the diagnosis and treatment of persons; pharmaceutical advice; medical consulting services in the field of diseasesillnesses and ailments in humans and animalsendocrine disordersnutritional and metabolic diseasesimmunity disordersblood disordersdisorders of the nervous system and sensory organsmusculoskeletal system disordersconnective tissue disorderscirculatory system disordersrespiratory system disordersdigestive system and genitourinary system disordersskin disorders
Publicações
Histórico de despachos e eventos da marca no USPTO.
61 publicações encontradas
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
28/08/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
28/08/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
28/08/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
28/08/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
28/08/2025
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
28/07/2025
8.PR
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED
28/07/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
21/04/2025
ES8R
TEAS SECTION 8 RECEIVED
22/10/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
30/10/2023
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
23/06/2022
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
04/02/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
23/11/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
23/11/2021
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
23/11/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
23/11/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
23/11/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
23/11/2021
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
30/10/2018
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
25/09/2018
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
25/09/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
24/09/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
24/09/2018
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
24/09/2018
GNS1
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
29/05/2018
GNSF
SUBSEQUENT FINAL EMAILED
29/05/2018
CFRC
SUBSEQUENT FINAL REFUSAL WRITTEN
29/05/2018
DOCK
ASSIGNED TO EXAMINER
08/05/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/04/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/04/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/04/2018
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
21/11/2017
GPRA
PRIORITY ACTION E-MAILED
21/11/2017
CPRA
PRIORITY ACTION WRITTEN
21/11/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
27/10/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
27/10/2017
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
23/10/2017
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
28/04/2017
GNFR
FINAL REFUSAL E-MAILED
28/04/2017
CNFR
FINAL REFUSAL WRITTEN
28/04/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/04/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/04/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/04/2017
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
25/01/2017
ALIE
ASSIGNED TO LIE
23/01/2017
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
29/12/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/10/2016
GNRT
NON-FINAL ACTION E-MAILED
07/10/2016
CNRT
NON-FINAL ACTION WRITTEN
07/10/2016
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
16/09/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
16/09/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
16/09/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
16/09/2016
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
16/09/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
30/03/2016
GNRT
NON-FINAL ACTION E-MAILED
30/03/2016
CNRT
NON-FINAL ACTION WRITTEN
30/03/2016
DOCK
ASSIGNED TO EXAMINER
25/03/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/12/2015
NWAP
NEW APPLICATION ENTERED
11/12/2015
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ZEALAND PHARMA A/S ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.